Is Puma Biotechnology, Inc. overvalued?

Puma Biotechnology, Inc. (PBYI) looks overvalued — trading about 41% above its fair value.

Overvalued

Price

$9.82

Fair value

$5.77

Current P/E

16.1

Normal P/E

9.5

Market cap

$499.8M

Dividend yield

0.0%

Return on equity

20.9%

Sector

Healthcare

Fair value compares PBYI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks